123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.
Yoshiyuki KitamuraShingo BabaTakuro IsodaYasuhiro MaruokaMasayuki SasakiTakeshi KamitaniYuhki KogaNaonori KawakuboToshiharu MatsuuraKousei IshigamiPublished in: Annals of nuclear medicine (2021)
Low 123I MIBG uptake using semi-quantitative SPECT/CT analysis was correlated with early relapse of NB.